Literature DB >> 18849363

Professional challenges of bedside rationing in intensive care.

Kristin Halvorsen1, Reidun Førde, Per Nortvedt.   

Abstract

As the pressure on available health care resources grows, an increasing moral challenge in intensive care is to secure a fair distribution of nursing care and medical treatment. The aim of this article is to explore how limited resources influence nursing care and medical treatment in intensive care, and to explore whether intensive care unit clinicians use national prioritization criteria in clinical deliberations. The study used a qualitative approach including participant observation and in-depth interviews with intensive care unit physicians and nurses working at the bedside. Scarcity of resources regularly led to suboptimal professional standards of medical treatment and nursing care. The clinicians experienced a rising dilemma in that very ill patients with a low likelihood of survival were given advanced and expensive treatment. The clinicians rarely referred to national priority criteria as a rationale for bedside priorities. Because prioritization was carried out implicitly, and most likely partly without the clinician's conscious awareness, central patient rights such as justice and equality could be at risk.

Entities:  

Mesh:

Year:  2008        PMID: 18849363     DOI: 10.1177/0969733008095383

Source DB:  PubMed          Journal:  Nurs Ethics        ISSN: 0969-7330            Impact factor:   2.874


  3 in total

1.  Thorny questions on the way to disclosing rationing.

Authors:  Marion Danis
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

2.  "Values that vanish into thin air": nurses' experience of ethical values in their daily work.

Authors:  Gro Bentzen; Anita Harsvik; Berit Støre Brinchmann
Journal:  Nurs Res Pract       Date:  2013-08-19

3.  Safe and competent nursing care: An argument for a minimum standard?

Authors:  Siri Tønnessen; Anne Scott; Per Nortvedt
Journal:  Nurs Ethics       Date:  2020-05-18       Impact factor: 2.874

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.